SHEENA KREMER: Open Payments
NPI 1689158669 · EVANSDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 53 payments from 16 companies in 2025. Trend: 2023 $540 · 2024 $889 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| Novo Nordisk Inc | 9 | $136 |
| ABBVIE INC. | 5 | $103 |
| PFIZER INC. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
Products named: Kerendia, Auvelity, CAPLYTA, AIRSUPRA, JARDIANCE, JOURNAVX, VRAYLAR, REXULTI.
Industry payments across IA — which companies pay providers there.
